Ireland
--:--IST
Latest
Clinical Trials in France / NCT06803914
Recruiting Observational

Analysis of Biomechanical Parameters and Return to Sport After Total Hip Replacement

NCT06803914 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-01-30
Last updated
2026-07-09

Condition(s) studied

Hip Arthroplasty, Total

Investigational drug(s) / intervention(s)

Biomechanical analysis

Biomechanical analysis: Biomechanical assessment is performed using a set of sensors (Qualisys Sports Marker Set - functional assessment, already in use at the Clinique du Sport) as well as 3D optoelectronic cameras and force and pressure platforms. These sensors are placed at various points on both lower limbs (hip, knee, ankle) and provide data in different planes (sagittal, frontal, transverse), as well as a comparison of both sides.

Study summary

This prospective study aims to evaluate the dynamic biomechanical parameters of gait in active patients who have undergone total hip replacement (THR), focusing on movements critical for return to sport.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patient scheduled for total hip replacement surgery * Active patient with low to high level of physical activity prior to surgery * Informed consent * Complete medical file Exclusion Criteria: * Contralateral hip surgery * Neurological disorder affecting movement (e.g. Parkinson's disease, stroke) * Spinal pathology affecting movement or posture * Dementia or inability to complete questionnaires and assessments * Pregnant or breast-feeding patient * Patient under protective supervision * Patient not covered by a social security scheme

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinique du Sport Mérignac France Recruiting

More Clinique du Sport, Bordeaux Mérignac trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06803914 on ClinicalTrials.gov ↗ ← All trials in France